| Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic Dermatitis (NCT07762833) | Galderma R&D | 2026-09-28 |
| Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic Dermatitis (NCT07660835) | Galderma R&D | 2026-07-13 |
| Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region (NCT07566286) | Galderma R&D | 2026-06-03 |
| A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis (NCT07047690) | Galderma R&D | 2026-02-20 |
| A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging (NCT07399028) | Galderma R&D | 2025-10-21 |
| Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO) (NCT07074977) | Galderma R&D | 2025-10-20 |
| A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris (NCT07186413) | Galderma R&D | 2025-09-23 |
| A Clinical Study to Assess Efficacy and Tolerability of a Topical Skincare Product on Adults With Mature, Crepey Skin (NCT07398989) | Galderma R&D | 2025-08-12 |
| A Clinical Study to Assess Histological Changes From Treatment of Poly L-lactic Acid Biostimulator on Women at Various Menopausal Stages (NCT07342400) | Galderma R&D | 2025-08-12 |
| Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults (NCT06988605) | Galderma R&D | 2025-07-14 |
| A Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital Lidocaine (NCT07047638) | Galderma R&D | 2025-07-09 |
| Evaluate the Effectiveness and Safety of Restylane Volyme in the Treatment of Temple Hollowing (NCT06665477) | Galderma R&D | 2024-11-18 |
| A Restylane Treatment Algorithm Approach for Participants With Appearance of Insufficient Bone Structure in the Lower Face Alone or in Combination With Facial Soft Tissue Deficiencies (NCT06428214) | Galderma R&D | 2024-05-13 |
| Comparing Pain, Safety and Effectiveness of Restylane Skinboosters Vital Lido and Vital Without Lido in Dorsal Hand (NCT06372782) | Galderma R&D | 2024-04-24 |
| A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients (NCT06357221) | Galderma R&D | 2024-04-08 |
| A Comparative Analysis of Two Hyaluronic Acid Fillers for Nasolabial Fold Correction (NCT06351293) | Galderma R&D | 2024-02-21 |
| Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies (NCT06351358) | Galderma R&D | 2024-02-19 |
| A Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction (NCT06161246) | Galderma R&D | 2023-10-23 |
| A Clinical Study to Assess the Efficacy and Safety of a Healing Ointment on Diaper Rash (NCT06015217) | Galderma R&D | 2023-08-25 |
| A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator with a Skincare Regimen (NCT05963204) | Galderma R&D | 2023-07-07 |
| Study to Evaluate the Safety and Effectiveness of GP0116 (NCT05987163) | Galderma R&D | 2023-04-12 |
| Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile (NCT05777759) | Galderma R&D | 2023-03-22 |
| Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing (NCT05691972) | Galderma R&D | 2023-03-14 |
| Effectiveness and Safety of Restylane Lyft Lidocaine for Jawline Definition (NCT05622812) | Galderma R&D | 2023-02-16 |
| Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines (NCT05148000) | Galderma R&D | 2023-01-23 |
| An Open-label Study of Poly-l-lactic Acid for Correction of Wrinkles in the décolletage Area (NCT05538728) | Galderma R&D | 2022-08-31 |
| Healing Ointment Usage Post-surgical Procedure (NCT05686928) | Galderma R&D | 2022-08-17 |
| A Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines (NCT05463965) | Galderma R&D | 2022-07-29 |
| Sculptra Chart Review (NCT05463978) | Galderma R&D | 2022-07-14 |
| Comparative Ultrasound Analysis of Two Hyaluronic Acid Dermal Fillers (NCT05622851) | Galderma R&D | 2022-07-12 |
| Safety and Effectiveness of Restylane® Kysse for Lip Augmentation in Chinese Subjects (NCT05342753) | Galderma R&D | 2022-06-13 |
| Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines (NCT05146999) | Galderma R&D | 2022-05-09 |
| Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies (NCT05262777) | Galderma R&D | 2022-05-02 |
| To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus (NCT05075408) | Galderma R&D | 2022-03-18 |
| Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction (NCT05098457) | Galderma R&D | 2022-02-22 |
| Study Comparing Treatment With Alluzience vs Reconstituted Toxin (NCT05277337) | Galderma R&D | 2022-02-04 |
| A Study to Evaluate the Durability of Response and Safety of Nemolizumab for 24 Weeks in Participants With Prurigo Nodularis (NCT05052983) | Galderma R&D | 2022-01-24 |
| AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation (NCT05089708) | Galderma R&D | 2021-12-22 |
| Safety and Effectiveness of Poly-l-lactic Acid (PLLA) for the Improvement in Appearance of Cellulite (NCT05064761) | Galderma R&D | 2021-11-19 |
| To Evaluate Effectiveness and Safety of GP0109 for Jawline Definition (NCT05110287) | Galderma R&D | 2021-11-15 |
| Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese Origin (NCT05089357) | Galderma R&D | 2021-11-11 |
| Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis (NCT04921345) | Galderma R&D | 2021-06-24 |
| Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation (NCT04856904) | Galderma R&D | 2021-05-28 |
| Study to Evaluate Satisfaction After Treatment With Restylane (NCT04638816) | Galderma R&D | 2021-04-16 |
| Main Study: A Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area Sub-study: A Follow-up Study to Evaluate the Analysis of Mammograms Following Treatment for Correction of Wrinkles in Décolletage Area in the Investigational Study 43USRV1906 (NCT04717934) | Galderma R&D | 2021-02-08 |
| New Dermal Filler for Chin Correction and Augmentation (NCT04631263) | Galderma R&D | 2021-01-29 |
| A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) (NCT04204616) | Galderma R&D | 2021-01-11 |
| Restylane Defyne in a Stepwise Treatment Approach (NCT04520997) | Galderma R&D | 2020-12-07 |
| Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) (NCT04501666) | Galderma R&D | 2020-09-11 |
| A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) (NCT04501679) | Galderma R&D | 2020-08-11 |
| A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV) (NCT04451330) | Galderma R&D | 2020-07-29 |
| A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study (NCT04269395) | Galderma R&D | 2020-04-07 |
| A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab (NCT04365387) | Galderma R&D | 2020-03-05 |
| Treatment of Moderate to Severe Glabellar Lines (NCT04249583) | Galderma R&D | 2020-02-10 |
| Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination (NCT04247074) | Galderma R&D | 2020-02-10 |
| Treatment of Moderate to Severe Lateral Canthal Lines (NCT04249687) | Galderma R&D | 2020-02-10 |
| Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines (NCT04225260) | Galderma R&D | 2020-01-27 |
| Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis (NCT03989206) | Galderma R&D | 2019-12-30 |
| Extension Study for 43USSA1705 (NCT04225273) | Galderma R&D | 2019-12-03 |
| Safety and Effectiveness of Sculptra Aesthetic for Correction of Cheek Wrinkles (NCT04124692) | Galderma R&D | 2019-11-12 |
| Open Label Extension for 43USSA1812 (NCT04595331) | Galderma R&D | 2019-11-12 |
| Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency (NCT04132518) | Galderma R&D | 2019-11-12 |
| Restylane-L for Correction of Infraorbital Hollows (NCT04154930) | Galderma R&D | 2019-11-11 |
| Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face (NCT04085367) | Galderma R&D | 2019-09-30 |
| Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands (NCT04080882) | Galderma R&D | 2019-09-25 |
| Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis (NCT03989349) | Galderma R&D | 2019-06-30 |
| Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis (NCT03985943) | Galderma R&D | 2019-06-27 |
| Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines (NCT03960957) | Galderma R&D | 2019-06-17 |
| Study to Evaluate Satisfaction After Treatment With Kysse (NCT03967444) | Galderma R&D | 2019-05-29 |
| A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD) (NCT03921411) | Galderma R&D | 2019-04-09 |
| Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris (NCT03915860) | Galderma R&D | 2019-03-27 |
| Safety and Effectiveness of Sculptra Aesthetic for Correction of Nasolabial Folds. (NCT03780244) | Galderma R&D | 2018-12-18 |
| Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines (NCT03736928) | Galderma R&D | 2018-11-26 |
| A Study to Evaluate Effectiveness and Safety of Hyaluronic Acid (HA) Fillers (NCT03869450) | Galderma R&D | 2018-11-09 |
| GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies (NCT03700047) | Galderma R&D | 2018-10-18 |
| Restylane Defyne for Correction of Chin Retrusion (NCT03597256) | Galderma R&D | 2018-10-08 |
| Subject Satisfaction With AbobutulinumtoxinA Treatment (NCT03687736) | Galderma R&D | 2018-10-02 |
| A Study to Evaluate the Safety and Efficacy of Restylane Defyne for Chin Augmentation and Correction of Chin Retrusion (NCT03624816) | Galderma R&D | 2018-08-21 |
| A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL) (NCT03292406) | Galderma R&D | 2017-12-19 |
| Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency (NCT03289052) | Galderma R&D | 2017-12-01 |
| New Dermal Filler for Lip Augmentation (NCT03320824) | Galderma R&D | 2017-11-13 |
| Safety and Efficacy of Nemolizumab in PN (NCT03181503) | Galderma R&D | 2017-10-02 |
| A Study to Evaluate the Performance and Safety of GP0045 for Correction of Moderate to Severe Nasolabial Folds (NCT03300466) | Galderma R&D | 2017-10-02 |